Modis Therapeutics Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$246M
Modis Therapeutics General Information
Description
Operator of a biopharmaceutical company intended to develop disease-modifying therapies for rare genetic diseases with a high unmet medical need. The company's therapeutics are under clinical development and focuses on treating thymidine kinase 2 deficiency (TK2d), an inherited mitochondrial disease, enabling medical professionals to improve nucleotide balance, increases mtDNA copy number, cell function and prolongs life.
Contact Information
Website
www.modistx.comCorporate Office
- 409 13th Street
- Suite 700
- Oakland, CA 94612
- United States
Corporate Office
- 409 13th Street
- Suite 700
- Oakland, CA 94612
- United States
Modis Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 09-Sep-2019 | $246M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 01-Oct-2018 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Startup |
Modis Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | ||||||||
| Series A1 |
Modis Therapeutics Comparisons
Industry
Financing
Details
Modis Therapeutics Competitors (65)
One of Modis Therapeutics’s 65 competitors is viDA Therapeutics, a Venture Capital-Backed company based in Vancouver, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| viDA Therapeutics | Venture Capital-Backed | Vancouver, Canada | ||||
| NGM Biopharmaceuticals | Private Equity-Backed | South San Francisco, CA | ||||
| Regenerx | Formerly VC-backed | Rockville, MD | ||||
| GeneCast Biotechnology | Private Equity-Backed | Wuxi, China | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA |
Modis Therapeutics Patents
Modis Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021034962-A1 | Polymorphic forms of deoxycytidine, compositions comprising the same and uses | Inactive | 19-Aug-2019 | ||
| JP-2021521210-A | A prodrug of deoxynucleosides for the treatment of diseases caused by an imbalanced nucleotide pool | Active | 12-Apr-2018 | ||
| WO-2019200340-A1 | Prodrugs of deoxynucleosides for treatment of diseases cased by unbalanced nucleotide pools | Inactive | 12-Apr-2018 | A61K31/7076 |
Modis Therapeutics Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aceras BioMedical | Venture Capital | Minority | ||
| Downstate's Biotechnology Incubator | Accelerator/Incubator | |||
| F-Prime | Venture Capital | Minority | ||
| OrbiMed | Growth/Expansion | Minority | ||
| Osage University Partners | Venture Capital | Minority |
Modis Therapeutics FAQs
-
When was Modis Therapeutics founded?
Modis Therapeutics was founded in 2016.
-
Where is Modis Therapeutics headquartered?
Modis Therapeutics is headquartered in Oakland, CA.
-
What industry is Modis Therapeutics in?
Modis Therapeutics’s primary industry is Drug Discovery.
-
Is Modis Therapeutics a private or public company?
Modis Therapeutics is a Private company.
-
What is the current valuation of Modis Therapeutics?
The current valuation of Modis Therapeutics is .
-
What is Modis Therapeutics’s current revenue?
The current revenue for Modis Therapeutics is .
-
How much funding has Modis Therapeutics raised over time?
Modis Therapeutics has raised $30M.
-
Who are Modis Therapeutics’s investors?
Aceras BioMedical, Downstate's Biotechnology Incubator, F-Prime, OrbiMed, and Osage University Partners have invested in Modis Therapeutics.
-
Who are Modis Therapeutics’s competitors?
viDA Therapeutics, NGM Biopharmaceuticals, Regenerx, GeneCast Biotechnology, and Inovio Pharmaceuticals are some of the 65 competitors of Modis Therapeutics.
-
When was Modis Therapeutics acquired?
Modis Therapeutics was acquired on 09-Sep-2019.
-
Who acquired Modis Therapeutics?
Modis Therapeutics was acquired by Zogenix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process